Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger ...
Bavarian Nordic A/S: Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...
Does Medicare Cover The Cost Of Flu Shots 2025?
Millions of people fall ill with the flu every year, and adults age 65 and older are at higher risk of developing serious ...
Medical Design and Outsourcing23h
Nasal vaccine devices: Design and regulatory need-to-knows
Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.
RFK Jr. has raised doubts about vaccines, but data shows how many lives they've saved
Robert F. Kennedy Jr., President Trump's new head of the Department of Health and Human Services, has raised doubts about vaccines — but history shows they've saved millions of lives.
Hosted on MSN13h
Can You Get Flu Shots Twice In The Same Year?
The CDC estimates that the 2024-2025 flu season has already resulted in at least 24 million illnesses, 310,000 ...
Bavarian Nordic gets FDA approval for chikungunya vaccine
Bavarian Nordic (OTCPK:BVNRY) has received FDA approval for its vaccine Vimkunya for the prevention of chikungunya. The virus-like particle, or VLP, vaccine is approved for people aged 12 and older.
Parents Warned Over 'Quad-demic' of COVID, Flu, Norovirus and RSV
The U.S. has seen earlier and more intense surges of the flu and RSV this year than is typical, pediatrician Dr. Ryan Fulton notes.